Approval · Notice of Compliance 4397 · 1996
RENEDIL: Notice of Compliance 4397
Issued June 6, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4397
- Date
- June 6, 1996
- Company
- Hoechst Marion Roussel Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antihypertensive agent
Products in this notice
Medicinal ingredients
- FELODIPINE 2.5 MG per TAB
- FELODIPINE 5 MG per TAB
- FELODIPINE 10 MG per TAB